tiprankstipranks
Advertisement
Advertisement

AGEN Stock Latest News

Agenus Announces Resignation of Principal Accounting Officer
Company AnnouncementsAgenus Announces Resignation of Principal Accounting Officer
6d ago
8K
AGEN
Agenus announces publication of Phase 1b BOT+BAL data
PremiumThe Fly
Agenus announces publication of Phase 1b BOT+BAL data
6d ago
AGEN
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
PremiumRatings
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
9d ago
AGEN
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
PremiumThe Fly
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
10d ago
BW
GM
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
PremiumThe Fly
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
10d ago
AGEN
Agenus provides 2026 strategic priorities
PremiumThe FlyAgenus provides 2026 strategic priorities
10d ago
AGEN
Agenus announces conclusion of SEC investigation with no enforcement action
Premium
The Fly
Agenus announces conclusion of SEC investigation with no enforcement action
10d ago
AGEN
AGEN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AGEN Earnings this Week: How Will it Perform?
12d ago
AGEN
Agenus appoints BAP Pharma as global partner for BOT+BAL access programs
PremiumThe Fly
Agenus appoints BAP Pharma as global partner for BOT+BAL access programs
30d ago
AGEN
Agenus reports Phase 2 results from BOT and BAL with agenT-797
PremiumThe Fly
Agenus reports Phase 2 results from BOT and BAL with agenT-797
1M ago
AGEN
Agenus announces first patient enrolled in Phase 3 BATTMAN trial of BOT+BAL
PremiumThe Fly
Agenus announces first patient enrolled in Phase 3 BATTMAN trial of BOT+BAL
2M ago
AGEN
Agenus: Strengthening Bot/Bal Clinical Profile and Capital-Efficient Path to Registration Underpin Positive Rating
PremiumRatings
Agenus: Strengthening Bot/Bal Clinical Profile and Capital-Efficient Path to Registration Underpin Positive Rating
2M ago
AGEN
Agenus Cervical Cancer Trial Terminated: What RaPiDS Means for AGEN Investors
PremiumCompany AnnouncementsAgenus Cervical Cancer Trial Terminated: What RaPiDS Means for AGEN Investors
2M ago
AGEN
Agenus Securities Class Action Dismissed, Legal Risks Ease
Premium
Company Announcements
Agenus Securities Class Action Dismissed, Legal Risks Ease
2M ago
8K
AGEN
Agenus: Advancing BATTMAN Phase 3 and Leveraging Zydus Partnership to Strengthen Risk‑Reward Profile and Support Buy Rating
Premium
Ratings
Agenus: Advancing BATTMAN Phase 3 and Leveraging Zydus Partnership to Strengthen Risk‑Reward Profile and Support Buy Rating
2M ago
AGEN
Options Volatility and Implied Earnings Moves Today, March 16, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 16, 2026
2M ago
NIU
AGEN
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
2M ago
M
MU
Agenus Inc. (AGEN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Agenus Inc. (AGEN) Q4 Earnings Cheat Sheet
2M ago
AGEN
Agenus triggers first $20M contingent payment under Zydus Lifesciences pact
PremiumThe Fly
Agenus triggers first $20M contingent payment under Zydus Lifesciences pact
2M ago
AGEN
Agenus Forms Major Strategic Collaboration with Zydus Lifesciences
PremiumCompany AnnouncementsAgenus Forms Major Strategic Collaboration with Zydus Lifesciences
4M ago
8K
AGEN
Agenus Consolidates Financial Leadership With Interim CFO Appointment
Premium
Company Announcements
Agenus Consolidates Financial Leadership With Interim CFO Appointment
4M ago
8K
AGEN
Agenus amends Ligand agreement, modifies warrant holder rights
Premium
Company Announcements
Agenus amends Ligand agreement, modifies warrant holder rights
4M ago
8K
AGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >